ACTIVE PHARMA AS: årsregnskap 2025 vs 2024
Grew 108111% on revenue, stronger earnings
approved 2026-06-09; registry 2026-06-30; journal 2026 603750
Summary
What changed
Comparing Årsregnskap 2025 with 2024 for ACTIVE PHARMA AS. Revenue 506 NOK → 547.5k NOK (+108111.1%). Net result +12.7k NOK → +87.1k NOK. Equity 47.1k NOK → 5.13m NOK.
On the constructive side: revenue rose; operating result improved; net result improved.
Also worth watching: payroll increased; book investments changed; headcount (årsverk) changed. All figures are taken from the published annual accounts for ACTIVE PHARMA AS.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 506 NOK to 547.5k NOK (+108111.1% YoY). Calculated
-
↑
Operating result improved
Operating result +12.4k NOK → +98.4k NOK (op. margin 2454.9% → 18.0%). Calculated
-
↑
Net result improved
Net result +12.7k NOK → +87.1k NOK (net margin 2511.5% → 15.9%). Calculated
-
↑
Equity strengthened
Book equity 47.1k NOK → 5.13m NOK (equity ratio 11.4% → 838.6%). Calculated
-
↑
Cash rose
Bank deposits 225.7k NOK → 462.5k NOK (+104.9% YoY). Calculated
Things to notice
-
·
Payroll increased
Salary cost 452.6k NOK → 1.38m NOK (89454% → 252% of revenue). Calculated
-
·
Book investments changed
Investment / intangible book value 46.4k NOK → 20.5k NOK. Reported fact
-
·
Headcount (årsverk) changed
Reported FTEs 0.3 → 1. Reported fact